KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Return on Equity (2016 - 2026)

Medpace Holdings filings provide 11 years of Return on Equity readings, the most recent being 0.01% for Q1 2026.

  • On a quarterly basis, Return on Equity changed 0.0% to 0.01% in Q1 2026 year-over-year; TTM through Mar 2026 was 0.01%, a 0.0% change, with the full-year FY2025 number at 0.01%, changed 0.0% from a year prior.
  • Return on Equity hit 0.01% in Q1 2026 for Medpace Holdings, down from 0.01% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.02% in Q3 2025 to a low of 0.0% in Q1 2022.
  • Median Return on Equity over the past 5 years was 0.01% (2023), compared with a mean of 0.01%.
  • The widest YoY moves for Return on Equity: up 1bps in 2022, down 0bps in 2022.
  • Medpace Holdings' Return on Equity stood at 0.01% in 2022, then dropped by -18bps to 0.01% in 2023, then decreased by -14bps to 0.0% in 2024, then skyrocketed by 153bps to 0.01% in 2025, then dropped by -27bps to 0.01% in 2026.
  • The last three reported values for Return on Equity were 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.02% (Q3 2025) per Business Quant data.